Wealth Manager - the site for professional investment managers

Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.

BlackRock & Schroders urge Astra to reopen Pfizer talks

3 Comments
BlackRock & Schroders urge Astra to reopen Pfizer talks

BlackRock and Schroders are understood to feature among a string of large shareholders in AstraZeneca who are urging the drugmaker to reopen takeover talks with Pfizer.

The FT reported that the groups have encouraged Astra to re-enter talks in August, after the group rejected Pfizer's 'final offer' of a £55 per share deal.

BlackRock represents Astra's largest shareholder wih a stake worth around 8%, and although the fund group has so far refrained from declaring its position, the FT reported that people close to BlackRock had said it backed Astra's rebuff of the £69.4 billion offer, but expects fresh negotiations to lead to an improved offer.

The FT also highlighted calls from Jupiter and Axa’s UK investment arm for more talks.

Leave a comment!

Please sign in or register to comment. It is free to register and only takes a minute or two.
Citywire TV
Play Biotech Growth: we will ride out this storm

Biotech Growth: we will ride out this storm

Geoffrey Hsu of Biotech Growth Trust says the sell-off in biotechnology stocks represents a buying opportunity for long-term investors.

Play Sector Spotlight: Kleinwort Benson's Choukeir on UK equities

Sector Spotlight: Kleinwort Benson's Choukeir on UK equities

In our first Sector Spotlight of the year we explore UK equities on the back of the extreme market turbulence in 2016.

Play Picton: the UK property hotspots for rental income

Picton: the UK property hotspots for rental income

Picton Property Income CEO Michael Morris reveals how he is planning to ride the ‘ripple effect’ as UK economic growth spills out from the capital across the country.

Your Business: Cover Star Club

Profile: PortfolioMetrix is on a mission to kill 'Frankenstein' systems

Profile: PortfolioMetrix is on a mission to kill 'Frankenstein' systems

In a buyers’ market for off-the-peg discretionary management, self-funded start-ups begin at an inherent disadvantage

Wealth Manager on Twitter